Taking the results of this study into consideration, targeting NECTIN4 has further advantages beyond serving as a landmark for drug recognition:NECTIN4 expression was significantly higher in angiosarcoma cells than normal endothelial cells. Here, NECTIN4 is linked to angiosarcoma.